INS and thyroid cancer: Metformin can inhibit insulin-induced growth stimulation in differentiated and undifferentiated thyroid cancer and thyroid cancer stem cells, and these effects of metformin are closely related to insulin/IGF signaling and AMPK/mTOR pathways [13].